U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07858019) titled 'A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers' on Sept. 03.
Brief Summary: This clinical trial has two parts. In Part A, the goal is to learn about the safety and tolerability of COR-2003 when it is given alone. In Part B, the goal is to learn about the safety and tolerability of COR-2003 and COR-1004 when given together.
The main questions it aims to answer in Part A are:
* How well is COR-2003 absorbed in the blood?
* Do any medical problems develop in participants taking COR-2003?
* How well do participants tolerate COR-2003 compared to a placebo (a look-alike injection that ...